• About us
• Contact

Advertisement

Product › Details

RACR/CAR payload architecture

	Next higher product group	in vivo cell therapy technology
	Status	2020-11-18 development existent
	Organisation	Umoja Biopharma, Inc.

Record changed: 2023-07-10

Advertisement

More documents for cell therapy technology

• [1] Orgenesis Inc.. (4/10/24). "Press Release: Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility". Ormond Beach, FL & Germantown,...
• [2] Bayer AG. (10/10/23). "Press Release: Bayer Invests 250 million USD in New Cell Therapy Manufacturing Facility in the U.S. [Not intended for US and UK Media]". Berlin....
• [3] Broken String Biosciences Ltd.. (10/2/23). "Press Release: Broken String Biosciences Strengthens Senior Leadership Team to Accelerate Product Development and Commercialization". Cambridge....
• [4] Agilent Technologies Inc.. (9/4/23). "Press Release: Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore". Singapore....
• [5] Synthego Corporation. (8/24/23). "Press Release: Synthego and bit.bio Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies". Redwood City, CA & Cambridge....
• [6] MicrofluidX Ltd.. (5/2/23). "Press Release: MicrofluidX and Immatics Working Together on Automated End-to-End Bioprocessing for TCR-T Therapies". Stevenage & Houston, TX....
• [7] Ori Biotech Ltd.. (12/15/22). "Press Release: Ori Biotech and Inceptor Bio Partner to Accelerate Solid Tumor Cell Therapy Access". London & Morrisville, NC....
• [8] Immatics N.V.. (10/10/22). "Press Release: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares". Houston, TX & Tübingen....
• [9] Ori Biotech Ltd.. (9/13/22). "Press Release: Ori Biotech and CTMC Partner to Accelerate Novel Cell Therapy Delivery". London & Houston, TX....
• [10] Immatics N.V.. (8/9/22). "Press Release: Immatics Announces Second Quarter 2022 Financial Results and Business Update". Tübingen & Houston, TX....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.